Nieuw vaccin tegen blauwtongvirus serotype 3 (BTV-3) voor schapen en runderen gelanceerd door Boehringer Ingelheim
Met deze lancering voegt Boehringer Ingelheim een vaccin tegen het blauwtongvirusserotype 3 (BTV3) toe aan haar portfolio van vaccins voor herkauwers. Het is een geïnactiveerd vaccin dat onderhuids wordt toegediend bij schapen en in de spier bij runderen
At Boehringer Ingelheim diversity of minds & collaboration is paramount to developing new medical breakthroughs. Click here see how you can partner with us.
Dealing with cancer can be difficult for all concerned. Here we have provided numerous resources of dedicated advice provided by patients, for patients.
Explore how Boehringer Ingelheim take on scientific challenges by doing things differently. Click here to read our latest science & innovation articles.
Click here to view our latest science success stories. It's important to reflect on the success of new medicines making patients lives significantly better.
Wereldwijde innovatie ten aanzien van diergezondheid
Animal Health Global Innovation Our Global Innovation team pioneers the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health today and in the future. We work collaboratively with our
Boehringer Ingelheim objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision.
Learn more on our goal to improve the lives of patients worldwide with medical breakthroughs and innovation, including over 100 products in the pipeline.
Discover where Boehringer Ingelheim's scientific research efforts and investment is currently focused on including CNS diseases, Retinal Health & COVID-19.
Click here to see Boehringer Ingelheim's latest featured stories. Explore our favourite stories highlighting the complex connection between animals and humans.